Cite
HARVARD Citation
Yuan, M. et al. (2022). Anlotinib Enhances the Antitumor Activity of High-Dose Irradiation Combined with Anti-PD-L1 by Potentiating the Tumor Immune Microenvironment in Murine Lung Cancer. Oxidative medicine and cellular longevity. p. . [Online].